WILLOW PHARMACY (DUNFERMLINE) LTDActive

Company number SC378671Private limited companyIncorporated 2010

Key figures

£840,079+7.4%
Net assets 2024/25
+4.8%
Average annual growth 2019/20–2024/25
0250 k500 k750 k1 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, WILLOW PHARMACY (DUNFERMLINE) LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand351,398328,573364,976523,186558,319
Total assets1,175,5571,150,7711,153,2641,311,2001,247,019
Total liabilities————382,384
Net assets / total equity666,512639,690652,045782,227840,079
Average number of employees111213150

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: WILLOW PHARMACY (DUNFERMLINE) LTD

Company

WILLOW PHARMACY (DUNFERMLINE) LTD is a private limited company registered with Companies House under company number SC378671. It was incorporated on 18 May 2010. Its status is active. The registered office is in Dunfermline (KY11). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Net assets were £840,079, up 7.4% on the previous year. Cash at bank and in hand was £558,319. Total assets were £1,247,019 and total liabilities £382,384. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered. 1 of 3 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 1 Jun 2027.